NuVasive Reports Fourth Quarter and Full Year 2015 Financial Results

Go back to NuVasive Reports Fourth Quarter and Full Year 2015 Financial Results

NuVasive (NUVA) PT Lowered at Piper Jaffray, Estimates Raised

February 12, 2016 7:26 AM EST

Piper Jaffray analyst Matt O'Brien lowered his price target on NuVasive (NASDAQ: NUVA) to $50.00 (from $59.00) following Q4 results but maintained a Overweight rating saying guidance was likely conservative.

commented, "This evening, NUVA reported full Q4 results and provided a more detailed 2016 outlook.... More

NuVasive (NUVA) Tops Q4 EPS by 4c, Offers FY16 Guidance

February 11, 2016 4:18 PM EST

NuVasive (NASDAQ: NUVA) reported Q4 EPS of $0.35, $0.04 better than the analyst estimate of $0.31. Revenue for the quarter came in at $215.3 million versus the consensus estimate of $215.27 million.

GUIDANCE:

NuVasive sees FY2016 EPS of $1.48, versus the consensus of $1.49. NuVasive sees FY2016... More